Fig. 1From: Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemiaPlatelet counts in different therapeutic groups. (a) Patients achieving CR (red), PR (blue) or NR (purple)acquired similar median platelet counts on day 7 after D-CAG (b) Patients achieving CR, PR or NR acquired similar median platelet counts on day 10 after D-CAG (C) Patients achieving CR acquired higher platelet counts compared with those achieving PR or NR on day 14 after D-CAGBack to article page